- Check here to see if your representative or senators are a co-sponsor of the bill.
- If they are a co-sponsor, send them a thank you email or tweet.
- If they are not, please send them an email or tweet asking them to consider co-sponsoring the bill.
Why is this important?
When a person receives a kidney transplant, immunosuppressive drugs prevent organ rejection.
- For most patients with kidney failure, a transplant is the optimal form of therapy that provides the highest quality of life and best clinical outcomes.
- For patients who are Medicare-eligible only because of kidney failure, Medicare provides immunosuppressive drug coverage for just 36 months, leaving patients to pay for the expensive drugs out-of- pocket, or risk organ failure and death.
- If the transplant fails, Medicare pays for patients to return to dialysis ($87,945 annually) or to receive a second transplant ($100,000).
- Immunosuppressive drugs cost just $4,008 annually.
Extending lifetime coverage of immunosuppressive drugs would prolong the lives of Americans, reduce taxpayer costs, allow more dialysis patients to consider a transplant, and preserve the scarce number of available kidneys.